Acura Pharmaceuticals Inc ACUR:OTCQB

RT Quote | Exchange | USD
Last | 05/13/21 EDT
0.3683UNCH (UNCH)
52 week range
0.15 - 0.50

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.3683
  • 52 Week High0.50
  • 52 Week High Date02/08/21
  • 52 Week Low0.15
  • 52 Week Low Date01/12/21

Key Stats

  • Market Cap8.14M
  • Shares Out22.10M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.66
  • YTD % Change75.36

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.3683
  • 52 Week High0.50
  • 52 Week High Date02/08/21
  • 52 Week Low0.15
  • 52 Week Low Date01/12/21
  • Market Cap8.14M
  • Shares Out22.10M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.66
  • YTD % Change75.36

RATIOS/PROFITABILITY

  • EPS (TTM)-0.04
  • P/E (TTM)-8.82
  • Fwd P/E (NTM)-3.07
  • EBITDA (MRQ)36,000.00
  • ROE (MRQ)13,209.72%
  • Revenue (MRQ)3.57M
  • Gross Margin (MRQ)4.20%
  • Net Margin (MRQ)-33.84%
  • Debt To Equity (MRQ)-106.42%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Acura Pharmaceuticals Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Acura Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. The Company has discovered and developed three platform technologies, which can be used to develop multiple products. The Company's Oxaydo Tablets (oxycodone HCl, CII), which utilizes the Aversion Technology, is an approved and immediate-release (IR) oxycodone product in...
Robert Jones
Chief Executive Officer
Peter Clemens
Chief Financial Officer
Albert Brzeczko Ph.D.
Vice President
Robert Seiser
Vice President
James Emigh
Vice President
Address
616 N North Ct Ste 120
Palatine, IL
60067-8121
United States

Top Peers

SYMBOLLASTCHG%CHG
BXRX
Baudax Bio Inc
0.765-0.0348-4.3511%
ARPO
Aerpio Pharmaceuticals Inc
1.07-0.09-7.76%
GTBP
GT Biopharma Inc
11.81-1.12-8.66%
ADMP
Adamis Pharmaceuticals Corp
0.6627-0.0185-2.7158%
PRPH
Prophase Labs Inc
5.56+0.17+3.15%